Liu Qianyi, Ruan Weishan, Liu Zhishang, Li Jiefeng, Li Jiayan
Department of Gastroenterology, Zhongshan City People's Hospital, Zhongshan, Guangdong Province, China.
Wideochir Inne Tech Maloinwazyjne. 2022 Sep;17(3):482-490. doi: 10.5114/wiitm.2022.114944. Epub 2022 Mar 27.
Achalasia (AC) is an esophageal motility disorder clinically manifested as dysphagia.
To investigate the effective factors of peroral endoscopic myotomy (POEM) for AC treatment.
A total of 182 AC patients treated between August 2019 and September 2020 were enrolled to receive POEM. They were assigned to an effective group (n = 143) and an ineffective group (n = 39). Their clinical data were recorded. The biochemical indices were determined.
Compared with the ineffective group, the Eckardt score and incidence of reflux 1 year after the operation were lower in the effective group, and the effective rate 6 months and 1 year after the operation was higher (p < 0.05). Significant differences were observed in drinking history, Eckardt score 1 year after the operation, hemoglobin (Hb), alanine aminotransferease (ALT), white blood cells (WBC), interleukin-6 (IL-6) and high sensitivity C-reactive protein (hs-CRP) between the two groups (p < 0.05). The Eckardt score 1 year after the operation, WBC, IL-6 and hs-CRP were lower, while the levels of Hb and ALT were higher in the effective group than those in the ineffective group. Multivariate logistic analysis revealed that drinking history, Eckardt score at 1 year after the operation, Hb, ALT, WBC, IL-6, and hs-CRP were independent factors affecting the therapeutic effect of POEM on AC. The results were well fitted by evaluation discrimination and calibration of the nomogram model, with good consistency.
POEM is safe, feasible and effective for AC treatment, based on factors such as drinking history, Eckardt score 1 year after the operation, Hb, ALT, WBC, IL-6, and hs-CRP.
贲门失弛缓症(AC)是一种食管动力障碍性疾病,临床表现为吞咽困难。
探讨经口内镜下肌切开术(POEM)治疗AC的影响因素。
选取2019年8月至2020年9月期间接受POEM治疗的182例AC患者。将他们分为有效组(n = 143)和无效组(n = 39)。记录他们的临床资料,测定生化指标。
与无效组相比,有效组术后1年的埃卡德特评分和反流发生率较低,术后6个月和1年的有效率较高(p < 0.05)。两组在饮酒史、术后1年埃卡德特评分、血红蛋白(Hb)、丙氨酸转氨酶(ALT)、白细胞(WBC)、白细胞介素-6(IL-6)和高敏C反应蛋白(hs-CRP)方面存在显著差异(p < 0.05)。有效组术后1年的埃卡德特评分、WBC、IL-6和hs-CRP较低,而Hb和ALT水平高于无效组。多因素逻辑回归分析显示,饮酒史、术后1年埃卡德特评分、Hb、ALT、WBC、IL-6和hs-CRP是影响POEM治疗AC疗效的独立因素。列线图模型的评估鉴别和校准结果拟合良好,一致性较好。
基于饮酒史、术后1年埃卡德特评分、Hb、ALT、WBC、IL-6和hs-CRP等因素,POEM治疗AC安全、可行且有效。